|EECP stands for "Enhanced External Counter Pulsation".
EECP is a new, US-FDA approved, non-invasive, outpatient treatment, which, when applied over a course of time, reduces anginal frequency, improves persons exercise capacity, and may even result in reduced need for medications. EECP is not a replacement for bypass surgery or angioplasty, but is an additional treatment for those patients who can no longer benefit from additional bypass surgery or angioplasty, and for whom medical therapy has already been maximized.
EECP is a treatment for heart patients that is
Macter International Pvt Limited is one of the leading pharmaceutical companies of Pakistan. It is well known for high quality and cost effective medicines in the medical community and manufactures pharmaceuticals for leading companies such as Wyeth-Lederle, Sandoz, Reckitt Benckiser, etc. Macter also markets international pharmaceutical brands in Pakistan on behalf of it's foreign partners.
One such company is Vasomedical Inc of USA. Macter International has exclusive marketing rights for Vasomedical's Enhanced External Counter Pulsation Device – EECP in Pakistan